Lenzilumab
Lenzilumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Lenzilumab is under investigation in clinical trial NCT02546284 (Study of Lenzilumab in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML)).
| Trade Name | Lenzilumab |
| Generic | Lenzilumab |
| Lenzilumab Other Names | Lenzilumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Lenzilumab
